Howard Zisser, M.D., Director of Clinical Research & Diabetes Technology, conducts clinical trials on new and innovative therapies for type 1, type 2 and gestational diabetes. He currently manages trials investigating JDRF and NIH funded Artificial Pancreas Projects, the safety and efficacy of inhaled insulin, and implantable insulin pumps and implantable glucose sensors. Additionally, Dr. Zisser is Adjunct Professor, Department of Chemical Engineering, University of California, Santa Barbara.
Dr. Zisser graduated summa cum laude from the University of Florida in Gainesville with a degree in Interdisciplinary Studies Biopharmacology and earned his medical degree from the Johns Hopkins University School of Medicine. He completed his residency in internal medicine at Santa Barbara Cottage Hospital. Dr. Zisser joined Sansum Diabetes Research Institute in 2002.